The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...

National Institutes of Health (NIH) Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research contracts because the general public does not ...

A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

Messenger RNA technology, better known as mRNA technology, made it possible to rapidly deploy a new vaccine during the COVID-19 pandemic — much earlier than would otherwise have been possible, saving ...